KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Non-cash Items: 2010-2018

Historic Non-cash Items for Alnylam Pharmaceuticals (ALNY) over the last 8 years, with Dec 2018 value amounting to $5.7 million.

  • Alnylam Pharmaceuticals' Non-cash Items rose 8.31% to $5.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $5.7 million, marking a year-over-year increase of 8.31%. This contributed to the annual value of $5.7 million for FY2018, which is 99.06% down from last year.
  • Latest data reveals that Alnylam Pharmaceuticals reported Non-cash Items of $5.7 million as of FY2018, which was down 99.06% from $609.6 million recorded in FY2017.
  • Alnylam Pharmaceuticals' Non-cash Items' 5-year high stood at $609.6 million during FY2017, with a 5-year trough of $4.7 million in FY2015.
  • For the 2-year period, Alnylam Pharmaceuticals' Non-cash Items averaged around $307.7 million, with its median value being $307.7 million (2017).
  • Per our database at Business Quant, Alnylam Pharmaceuticals' Non-cash Items skyrocketed by 37.16% in 2014 and then plummeted by 99.06% in 2018.
  • Yearly analysis of 4 years shows Alnylam Pharmaceuticals' Non-cash Items stood at $478.5 million in 2014, then plummeted by 99.02% to $4.7 million in 2015, then reached $609.6 million in 2017, then slumped by 99.06% to $5.7 million in 2018.